Ultimovacs ASA (OSL:ZLNA)
Norway flag Norway · Delayed Price · Currency is NOK
17.80
-0.70 (-3.78%)
At close: Apr 1, 2025

Ultimovacs ASA Statistics

Total Valuation

Ultimovacs ASA has a market cap or net worth of NOK 374.20 million.

Market Cap 374.20M
Enterprise Value n/a

Important Dates

The next estimated earnings date is Wednesday, April 2, 2025.

Earnings Date Apr 2, 2025
Ex-Dividend Date n/a

Share Statistics

Ultimovacs ASA has 20.23 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class n/a
Shares Outstanding 20.23M
Shares Change (YoY) +0.02%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 12
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.58% in the last 52 weeks. The beta is 0.78, so Ultimovacs ASA's price volatility has been lower than the market average.

Beta (5Y) 0.78
52-Week Price Change -75.58%
50-Day Moving Average 2.24
200-Day Moving Average 3.78
Relative Strength Index (RSI) 33.35
Average Volume (20 Days) 239,525

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income n/a
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Ultimovacs ASA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.02%
Shareholder Yield -0.02%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a